REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial. Issue 11 (November 2022)

• Record Type: Journal Article
• Authors: Salabati, Mirataollah; Mahmoudzadeh, Raziyeh; Starr, Matthew R.; Zhang, Qiang; Sharpe, James; Hsu, Jason; Ho, Allen C.; Regillo, Carl; Kuriyan, Ajay E.
• Is Part Of: Retina. Volume 42:Issue 11(2022)
• Page Start: 2059
• Page End: 2065
• Publication Date: 2022-11
• Subjects: refractive error -- diabetic macular edema -- aflibercept -- ranibizumab -- bevacizumab; Retina -- Diseases -- Periodicals; Retinal Diseases; Vitreous Body; 617.735
• DOI: 10.1097/IAE.0000000000003583
• Languages: English
• ISSNs: 0275-004X

Abstract

Abstract : Supplemental Digital Content is Available in the Text. Patients with diabetic macular edema undergoing anti–vascular endothelial growth factor injections experience minimal changes in their refractor error. Therefore, proper correction and spectacle prescription should be considered for these patients regardless of degree of macular edema. Abstract : Purpose: To evaluate the impact of anti–vascular endothelial growth factor therapy on the refractive error in eyes with diabetic macular edema. Methods: Post hoc analysis of Diabetic Retinopathy Clinical Research protocol T. Spherical equivalent (SE) was calculated for study and fellow eyes at baseline, 1-year, and 2-year visits. The SE change of the eyes with edema was compared with those with resolved edema. The correlation between refractive error changes and central subfield thickness was evaluated. Results: Among 543 study eyes, SE changed from −0.17 (2.04) D at baseline visit to −0.16 (2.14) D at 2 years giving a hyperopic shift of 0.04 (0.82) D ( P = 0.022). Among fellow eyes, mean (SD) SE changed from −0.19 (2.1) D at baseline to −0.11 (2.1) D at 2 years, giving a hyperopic shift of 0.12 (0.84) D ( P = 0.001). No significant difference in SE shift was found between eyes with and without edema at 2 years in phakic (0.12D and 0.08 D, P = 0.87) and pseudophakic eyes (−0.24D and −0.08D, P = 0.30). The SE shift was not correlated with central subfield thickness change at the end of the second year (r = 0.02, P = 0.62). Conclusion: Diabetic macular edema patients have minimal changes in refractive error. The correction of refractive error may be considered during treatment, regardless of the presence of edema.